USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark ROSEMONT was filed as Word mark on 11/18/2005 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 08/11/2009.
The current status of the mark is "CANCELLED - SECTION 8".
| Trademark form | Word mark |
| File reference | 78757023 |
| Register number | 3666809 |
| Application date | November 18, 2005 |
| Publication date | May 26, 2009 |
| Entry date | August 11, 2009 |
Trademark owner
BRAITHWAITE STREET
LS119XE LEEDS
GB
LS119XE LEEDS
GB
Trademark representatives
goods and services
5
Liquid pharmaceuticals, namely, Antibacterial pharmaceuticals, Anti-diabetic pharmaceuticals, Cardiovascular pharmaceuticals, Lipid lowering agents, Psychotropics, and Anti-infectives; Liquid pharmaceutical preparations, namely, anticoagulants; Liquid pharmaceutical preparations, namely, antidepressants; Liquid pharmaceutical preparation for the treatment of gout; Liquid pharmaceutical preparations for the treatment of heart rhythm disorders; Liquid pharmaceutical preparations acting on the central nervous system; Liquid pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Liquid pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Liquid pharmaceutical preparations for treating diabetes; Liquid pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Liquid pharmaceutical preparations for the treatment of inflammatory disorders; Liquid pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Liquid pharmaceutical products for the treatment of bone diseases; Liquid pharmaceutical products for the treatment of viral and infectious diseases, and for the treatment of cancer
ID: 1378757023